You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
11 June 2024
Tacalyx Extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs
5 November 2020
Tacalyx Appoints Dr. Klaus Schollmeier as Chairman of the Board
